Compare BEEM & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEEM | BCTX |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | Canada |
| Employees | 220 | 4 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 26.6M |
| IPO Year | N/A | 2025 |
| Metric | BEEM | BCTX |
|---|---|---|
| Price | $1.15 | $3.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $3.50 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 395.2K | 102.1K |
| Earning Date | 04-09-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.48 | N/A |
| Revenue Next Year | $32.17 | $380.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.97 | $0.63 |
| 52 Week High | $4.04 | $14.68 |
| Indicator | BEEM | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 47.10 |
| Support Level | $1.13 | $3.27 |
| Resistance Level | $1.66 | $4.51 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 88.08 | 26.73 |
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.